Načítá se...
COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine has garnered immense global interest. Less than a year after COVID-19 was declared a pandemic, several vaccine candidates had received emergency use authorization across a range of countries. Despite this scientific break...
Uloženo v:
| Vydáno v: | Health Policy |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Author(s). Published by Elsevier B.V.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7997052/ https://ncbi.nlm.nih.gov/pubmed/33820678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.healthpol.2021.03.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|